Threshold Pharmaceuticals Inc. (NASDAQ:THLD) is scheduled to post its quarterly earnings results after the market closes on Thursday, July 28th. Analysts expect Threshold Pharmaceuticals to post earnings of ($0.10) per share for the quarter.
Threshold Pharmaceuticals (NASDAQ:THLD) last posted its quarterly earnings data on Thursday, May 5th. The biotechnology company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.02) by $0.09. On average, analysts expect Threshold Pharmaceuticals to post $-0.4100 EPS for the current fiscal year and $-0.4200 EPS for the next fiscal year.
Threshold Pharmaceuticals Inc. (NASDAQ:THLD) traded down 2.8937% on Wednesday, hitting $0.5235. The stock had a trading volume of 671,933 shares. The company has a market cap of $37.44 million and a price-to-earnings ratio of 0.9010. Threshold Pharmaceuticals Inc. has a 52-week low of $0.21 and a 52-week high of $5.28. The company has a 50 day moving average price of $0.51 and a 200-day moving average price of $0.42.
Threshold Pharmaceuticals, Inc is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib.
